These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1395170)

  • 1. Decrease of tumor-like calcification in uremia despite aggravation of secondary hyperparathyroidism: a case report.
    Geffriaud C; Allinne E; Page B; Zingraff J; Jucquel JP; Bardin T; Drüeke TB
    Clin Nephrol; 1992 Sep; 38(3):158-61. PubMed ID: 1395170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumoral calcifications in hemodialysis patients: possible role of aluminum intoxication.
    Zins B; Zingraff J; Basile C; Petitclerc T; Ureña P; Bardin T; Drüeke T
    Nephron; 1992; 60(3):260-7. PubMed ID: 1565177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal ostodystrophy during the developing stage of maintenance dialysis in Transylvania. Early development of periarticular calcifications and beta 2 microglobulin amyloidosis in spite of a relatively good prevention of secondary hyperparathyroidism.
    Oprisiu R; Bolosiu H; Boca I; Theodoru C; Elefterescu R; Brazier M; el Esper I; Leflon P; Ledeme C; Fournier A; Heinze V
    Ann Med Interne (Paris); 1998 Mar; 149(2):67-75. PubMed ID: 11490527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits.
    Hamada J; Tamai K; Ono W; Saotome K
    J Rheumatol; 2006 Jan; 33(1):119-26. PubMed ID: 16395759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial calcification and tumoural calcinosis during vitamin D therapy.
    Seyahi N; Apaydin S; Sariyar M; Serdengecti K; Erek E
    Nephrology (Carlton); 2004 Apr; 9(2):89-93. PubMed ID: 15056268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary hyperparathyroidism in patients on long-term hemodialysis].
    Janda J
    Zentralbl Allg Pathol; 1986; 132(5-6):523-31. PubMed ID: 3564736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does vitamin K excess induce ectopic calcifications in hemodialysis patients?
    Robert D; Jorgetti V; Leclercq M; Lacour B; Ulmann A; Bourdeau A; Drüeke T
    Clin Nephrol; 1985 Dec; 24(6):300-4. PubMed ID: 3878250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic tumoral calcinosis: preliminary observations suggesting an association with aberrant vitamin D homeostasis.
    Quarles LD; Murphy G; Econs MJ; Martinez S; Lobaugh B; Lyles KW
    Am J Kidney Dis; 1991 Dec; 18(6):706-10. PubMed ID: 1962658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis.
    Kim SJ; Goldstein M; Szabo T; Pierratos A
    Am J Kidney Dis; 2003 Mar; 41(3):E12. PubMed ID: 12613005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
    Henley C; Colloton M; Cattley RC; Shatzen E; Towler DA; Lacey D; Martin D
    Nephrol Dial Transplant; 2005 Jul; 20(7):1370-7. PubMed ID: 15855208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of alkaline calcium salts as phosphate binder in uremic patients.
    Fournier A; Morinière P; Ben Hamida F; el Esjer N; Shenovda M; Ghazali A; Bouzernidj M; Achard JM; Westeel PF
    Kidney Int Suppl; 1992 Oct; 38():S50-61. PubMed ID: 1405382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats.
    Lopez I; Mendoza FJ; Aguilera-Tejero E; Perez J; Guerrero F; Martin D; Rodriguez M
    Kidney Int; 2008 Feb; 73(3):300-7. PubMed ID: 18004298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
    Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Periaticular metastatic calcifications in uremic patients].
    Fabbri L; Fusaroli M; Catizone L; Zucchelli P
    Minerva Med; 1975 Jan; 66(5):209-19. PubMed ID: 1113921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism.
    Lin SH; Shieh SD; Chyr SH; Lu KC; Lin YF; Diang LK; Chou TC; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):240-5. PubMed ID: 7982134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction between active metabolites of vitamin D3 and blood aluminum in chronic uremic patients on dialysis].
    Panico F; Salvati A; Scoppa F; Testa GF; Capobianco A; Pacia S; Lauriello F; Aquino A; Tedesco V; Taccone W
    Minerva Urol Nefrol; 1993 Jun; 45(2):47-8. PubMed ID: 8235931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant metastatic calcinosis with cutaneous necrosis in a child with end-stage renal disease and tertiary hyperparathyroidism.
    Zouboulis CC; Blume-Peytavi U; Lennert T; Stavropoulos PG; Schwarz A; Runkel N; Trautmann C; Orfanos CE
    Br J Dermatol; 1996 Oct; 135(4):617-22. PubMed ID: 8915159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.